Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns

Journal of Chemotherapy

Volumn 25, Issue 4, 2013, Pages 217-221

  Kosmidis, Chris ^a   Giannopoulou, Maria ^a   Flountzi, Anastasia ^a   Markogiannakis, Antonis ^a   Goukos, Dimitris ^a   Petrikkos, George ^a   Daikos, George L ^a   Tzanetou, Konstantina ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Aminoglycosides; Enterobacteriaceae; Molecular mechanisms; Prescription patterns; Resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN; NEOMYCIN; NETILMICIN; SPECTINOMYCIN; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DISK DIFFUSION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; GENE SEQUENCE; GENETIC ANALYSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE;

EID: 84880956188     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947813Y.0000000073     Document Type: Article

References (20)

1. Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev. 2003; 16(3):430-50.
2. Miller GH, Sabatelli FJ, Hare RS, Glupczynski Y, Mackey P, Shlaes D, et al. The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis. 1997;24 Suppl 1:S46-62.
3. Miller GH, Sabatelli FJ, Naples L, Hare RS, Shaw KJ. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin - a new broad-spectrum aminoglyco-side. The Aminoglycoside Resistance Study Groups. J Chemother. 1995;7 Suppl 2:31-44.
4. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. M100-S22, 2012, CLSI, Wayne, PA, USA.
5. Daikos GL, Kosmidis C, Tassios PT, Petrikkos G, Vasilakopoulou A, Psychogiou M, et al. Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome. Antimicrob Agents Chemother. 2007;51(7):2366-72.
6. Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother. 1991;35(7):1284-90.
7. Gerding DN. Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol. 2000;21(1 Suppl):S12-7.
8. Francetic I, Kalenic S, Huic M, Mercep I, Makar-Ausperger K, Likic R, et al. Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study. Croat Med J. 2008;49(2):207-14.
9. Psichogiou M, Tassios PT, Avlamis A, Stefanou I, Kosmidis C, Platsouka E, et al. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother. 2008;61(1):59-63.
10. Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S, et al. Microbiological and molecular character-istics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill. 2012;17(7).
11. Kontopoulou K, Protonotariou E, Vasilakos K, Kriti M, Koteli A, Antoniadou E, et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resis-tant to colistin. J Hosp Infect. 2010;76(1):70-3.
12. Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, et al. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50(3):364-73.
13. Galani I, Xirouchaki E, Kanellakopoulou K, Petrikkos G, Giamarellou H. Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece. Clin Microbiol Infect. 2002;8(9):579-88.
14. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006;50(12):4114-23.
15. Garza-Ramos U, Morfin-Otero R, Sader HS, Jones RN, Hernandez E, Rodriguez-Noriega E, et al. Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother. 2008;52(8):2943-6.
16. Sandvang D, Aarestrup FM. Characterization of aminoglyco-side resistance genes and class 1 integrons in porcine and bovine gentamicin-resistant Escherichia coli. Microb Drug Resist. 2000;6(1):19-27.
17. Sunde M, Norstrom M. The genetic background for strepto-mycin resistance in Escherichia coli influences the distribution of MICs. J Antimicrob Chemother. 2005;56(1):87-90.
18. Gebreyes WA, Thakur S. Multidrug-resistant Salmonella enterica serovar Muenchen from pigs and humans and potential interserovar transfer of antimicrobial resistance. Antimicrob Agents Chemother. 2005;49(2):503-11.
19. Galimand M, Courvalin P, Lambert T. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother. 2003;47(8):2565-71.
20. Yan JJ, Wu JJ, Ko WC, Tsai SH, Chuang CL, Wu HM, et al. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother. 2004;54(6):1007-12.